Discover a New Approach to the ED Opioid Crisis
On Demand Webinar
Identify, Engage, and CONVERT the Hidden Opiate Users in your Emergency Department.
Research shows that 16 states experienced a 35% increase in ED visits for suspected overdoses in just 15 months from July 2016 through September 2017.
Join us as Kathy Smith, Ph.D, COO, and Michael Rhoades, CEO, of population health improvement consulting firm, Blaze Advisors shares a new and innovative identification and intervention methodology called, CONVERT.
In this webinar, you’ll learn:
- An innovative approach to early identification of rising risk opioid users
- CONVERT’s multi-step approach to opioid intervention
- How the program is designed to identify and address opiate use challenges in a safety net hospital system
Speaker: Kathy Smith, Ph.D
Kathy is a licensed psychologist dedicated to making a difference in the lives of individuals, families, and communities facing mental health, substance use, and/or intellectual and developmental disabilities. Over the last 20 years, Kathy has worked in various settings including schools, state facilities, private practice, and community/public behavioral health. She has served as a psychologist, a Chief Clinical Officer, and most recently as Chief Operating Officer of a large community based behavioral health provider serving individuals with mental health, substance use, and co-occurring disorders.
Speaker: Mike Rhoades, MBA
Mike is CEO and Founder of Blaze Advisors, a leader in strategic planning and execution of High Performance, Clinically Integrated health networks. Mike has served in a variety of executive and advisory roles including COO of a multi-state IDN, CEO of ambulatory multi-specialty network, and senior executive for a 2 million life Accountable Care Organization where he architected and commercialized cross-platform care management, analytics, and health information exchange tools for 23,000 physicians and 120 hospitals. In addition, Mike has broad industry experience serving as Managing Director in a regional private equity network for over 15 years and deep ties in the Medical Device, Digital Health, and Life Sciences verticals.